Most lately, it has been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger https://russellh197iiy9.thechapblog.com/profile